Human Prothrombin Complex market was valued at US$ 1577 million in 2022 and is anticipated to reach US$ 3473.8 million by 2029, witnessing a CAGR of 11.8% - Valuates Reports

Human Prothrombin Complex market was valued at US$ 1577 million in 2022 and is anticipated to reach US$ 3473.8 million by 2029, witnessing a CAGR of 11.8% during the forecast period 2023-2029.

Get sample report - https://reports.valuates.com/request/sample/QYRE-Auto-36M446/Global_Human_Prothrombin_Complex_Market_Insights_and_Forecast_to_2028

Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.

This report aims to provide a comprehensive presentation of the global market for Human Prothrombin Complex, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
The Human Prothrombin Complex market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Human Prothrombin Complex market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Prothrombin Complex manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Segment by Type
500 IU/Vial
600 IU/Vial
1000 IU/Vial
Others

Segment by Application
Hemophilia B
Vitamin K Deficiency
Others

Get detailed report - https://reports.valuates.com/market-reports/QYRE-Auto-36M446/global-human-prothrombin-complex

Similar report -

https://reports.valuates.com/market-reports/QYRE-Auto-4Y14020/global-human-plasma-derived-therapeutics

https://reports.valuates.com/market-reports/QYRE-Auto-0Z9240/global-human-prothrombin-complex

https://reports.valuates.com/market-reports/QYRE-Auto-21F3040/global-human-plasma-derived-therapeutics

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

Phone:
U.S. (TOLL FREE) : +1 (315) 215-3225
India: +91 8040957137

Email Id:
Please reach us at sales@valuates.com

This release was published on openPR.